74 related articles for article (PubMed ID: 16889383)
1. Expression of single-chain Fv gene specific for gamma-seminoprotein by RTS and its biological activity identification.
Han Y; Haun Y; Deng J; Gao F; Pan B; Cui D
Biotechnol Prog; 2006; 22(4):1084-9. PubMed ID: 16889383
[TBL] [Abstract][Full Text] [Related]
2. [Prokaryotic expression and bioactivity identification of Fab against human gamma-seminoprotein].
Sun JF; Yang J; Hao XK; Zhao J; Wen WH; Jin M; Wang CJ; Yang AG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):483-5. PubMed ID: 15169664
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
Hao XK; Liu JY; Yue QH; Wu GJ; Bai YJ; Yin Y
Prostate; 2006 Jun; 66(8):858-66. PubMed ID: 16491483
[TBL] [Abstract][Full Text] [Related]
4. [Screening of human anti-gamma-seminoprotein light chain guided with the murine Fd fragment].
Zhang Q; Zhang SH; Yi J; Su MQ; Bao GQ; Hao XK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):196-9. PubMed ID: 16507258
[TBL] [Abstract][Full Text] [Related]
5. Guided selection of an anti-gamma-seminoprotein human Fab for antibody directed enzyme prodrug therapy of prostate cancer.
Zhang Q; Zhang SH; Su MQ; Bao GQ; Liu JY; Yi J; Shen JJ; Hao XK
Cancer Immunol Immunother; 2007 Apr; 56(4):477-89. PubMed ID: 16868778
[TBL] [Abstract][Full Text] [Related]
6. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
[TBL] [Abstract][Full Text] [Related]
7. [Biologic activity of bispecific single chain antibody against human gamma-seminoprotein and CD3 molecule].
Wang D; Wang H; Wu GJ; Wu WZ; Yang SL; Lin WH; Tan JM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):500-3. PubMed ID: 16806016
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of single chain Fv directed against beta2-agonist clenbuterol.
Pan K; Wang H; Zhang HB; Liu HW; Lei HT; Huang L; Sun YM
J Agric Food Chem; 2006 Sep; 54(18):6654-9. PubMed ID: 16939323
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural localizations of beta-microseminoprotein, a prostate-specific antigen, in human prostate and sperm: comparison with gamma-seminoprotein, another prostate-specific antigen.
Ito Y; Tsuda R; Kimura H
J Lab Clin Med; 1989 Sep; 114(3):272-7. PubMed ID: 2475560
[TBL] [Abstract][Full Text] [Related]
10. Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging.
Serda RE; Adolphi NL; Bisoffi M; Sillerud LO
Mol Imaging; 2007; 6(4):277-88. PubMed ID: 17711783
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
[TBL] [Abstract][Full Text] [Related]
12. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
[TBL] [Abstract][Full Text] [Related]
13. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.
Morgenroth A; Cartellieri M; Schmitz M; Günes S; Weigle B; Bachmann M; Abken H; Rieber EP; Temme A
Prostate; 2007 Jul; 67(10):1121-31. PubMed ID: 17492652
[TBL] [Abstract][Full Text] [Related]
14. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
16. [Construction, expression and functional characterization of single chain variable fragments (scFv) against human CD33 antigen].
Chen XJ; Wang Y; Qu H; Ge XS; Zuo YF; Liao XL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1147-9. PubMed ID: 18062889
[TBL] [Abstract][Full Text] [Related]
17. Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody.
Hao CH; Han QH; Shan ZJ; Hu JT; Zhang N; Zhang XP
Theor Biol Med Model; 2015 Aug; 12():14. PubMed ID: 26246000
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.
Donà MG; Giorgi C; Accardi L
BMC Cancer; 2007 Jan; 7():25. PubMed ID: 17266749
[TBL] [Abstract][Full Text] [Related]
19. Fully automated immunoassay for detection of prostate-specific antigen using nano-magnetic beads and micro-polystyrene bead composites, 'Beads on Beads'.
Matsunaga T; Maeda Y; Yoshino T; Takeyama H; Takahashi M; Ginya H; Aasahina J; Tajima H
Anal Chim Acta; 2007 Aug; 597(2):331-9. PubMed ID: 17683747
[TBL] [Abstract][Full Text] [Related]
20. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
